Centogene Company

CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients.
Technology: Pregnancy biomarkers, Biomarkers of Female Cancers
Industry: Mitochondrial Genetics
Headquarters: Germany
Founded Date: 2016
Funding Status: Series A
Investors Number: 4
Total Funding: $29 M
Estimated Revenue: $50M to $100M
Last Funding Type: Grant

Visit Website
Register and Claim Ownership